Sema6A and Mical1 control cell growth and survival of BRAF V600E human melanoma cells

Supplementary Material
Figure S1: Scatter plots of differentially expressed genes in BRAF-mutant and NRAS-mutant melanoma clones. Comparison of gene expression in three BRAF-mutant melanoma clones (2/21, 2/33, 2/59) and in three NRAS-mutant melanoma clones (2/4, 2/14, 2/17) isolated from the same metastatic cell line 665/2. Whole genome gene expression profiling of the indicated clones was carried out as described in Materials and Methods. For each gene, the average expression level, based on values from three independent biological replicates, is shown. Genes located outside of the diagonal red lines have at least a three-fold difference in expression levels between BRAF-mutant and NRAS-mutant clones. Sema6A and Mical1 are identified by red symbols. 4 of BRAF mutant cells, after depletion of Sema6A, were assessed for their ability to migrate and invade matrigel. Each assays was carried out in quadruplicate and repeated at least three times. Statistical differences were evaluated by T test (p<0.0001) Figure S7 : Chemoinvasion assay. Invasion assay (upper and lower panels) of NRAS/siSema6A clones 2/17 and 2/14. 3x10 4 of NRAS mutant cells, after depletion of Sema6A, were assessed for their ability to invade matrigel. Each assays was carried out in quadruplicate and repeated at least three times. Statistical differences were evaluated by T test (p<0.0001). (10538, 4686, 4023, 18732, 18656, 15392, 14464) or NRAS Q61R clones (2/4, 2/14, 2/17, and 2/51) were analyzed by WB for expression of Plexin-A4. (C) Expression of the reported protein and cell signaling analyzed by WB on Ctrl, siScr and both siSema6A/Plexin4/BRAF V600E on clone 2/59. clones (2/14 and 2/17) were injected intracardially in four (#1-#4) and in three (#1-#3) mice, respectively. After 5 weeks, mice were sacrificed; excised selected organs were analyzed for presence (+) or not (-) of metastases. The BRAF V600E clones gave metastases to all organs with the exception of spleen, and in some cases more then one metastasis. Only the NRAS Q61R clone 2/17 was able to give two metastases, in the intestine and in the stomach respectively in one-mouse. 6 cells of NRAS Q61R overexpressing Sema6A clones (2/17/Sema6A and 2/14/Sema6A) were injected in five and in four mice, respectively (#1-#5 and #1-#4); After 7 weeks, mice were sacrificed; excised selected organs were analyzed for presence (+) or not (-) of metastases. The NRAS Q61R /Sema6A clones were highly metastatic in skeleton, lung, pancreas and heart compared to NRAS Q61R clones.
